BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 21425209)

  • 1. Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation.
    Garrity-Park M; Loftus EV; Sandborn WJ; Smyrk TC
    Inflamm Bowel Dis; 2012 Feb; 18(2):275-83. PubMed ID: 21425209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The study of methylation and single nucleotide polymorphisms of cancer-related genes in patients with early-stage ulcerative colitis.
    Chen HX; Yuan ZY; Wu KX; Liu C; Mao QD; He BG; Yuan H
    Scand J Gastroenterol; 2019 Apr; 54(4):427-431. PubMed ID: 31046486
    [No Abstract]   [Full Text] [Related]  

  • 3. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative Colitis.
    Garrity-Park MM; Loftus EV; Bryant SC; Smyrk TC
    Inflamm Bowel Dis; 2016 Jul; 22(7):1568-74. PubMed ID: 27135485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Bryant SC; Sandborn WJ; Smyrk TC
    Am J Gastroenterol; 2008 Feb; 103(2):407-15. PubMed ID: 18289203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
    Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
    Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
    Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
    Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms.
    Connelly TM; Berg AS; Harris LR; Brinton DL; Hegarty JP; Deiling SM; Stewart DB; Koltun WA
    Surgery; 2014 Aug; 156(2):253-62. PubMed ID: 24947639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of RUNX3 Immunoreactivity in Non-Neoplastic Rectal Mucosa May Predict the Occurrence of Ulcerative Colitis-Associated Colorectal Cancer.
    Shinagawa T; Hata K; Morikawa T; Matsunaga K; Emoto S; Murono K; Kaneko M; Sasaki K; Nishikawa T; Tanaka T; Kawai K; Nozawa H; Fukayama M; Ishihara S
    Digestion; 2020; 101(2):156-164. PubMed ID: 30763934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
    Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
    Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
    Wang ZL; Wang YD; Wang K; Li JA; Li L
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
    Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
    Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Anti-tumour Necrosis Factor Agents on the Risk of Colorectal Cancer in Patients with Ulcerative Colitis: Nationwide French Cohort Study.
    Charkaoui M; Hajage D; Tubach F; Beaugerie L; Kirchgesner J
    J Crohns Colitis; 2022 Jul; 16(6):893-899. PubMed ID: 34657962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect.
    Kisiel JB; Garrity-Park MM; Taylor WR; Smyrk TC; Ahlquist DA
    Inflamm Bowel Dis; 2013 Sep; 19(10):2079-83. PubMed ID: 23867875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Never in mitosis gene A-related kinase 6 and aurora kinase A: New gene biomarkers in the conversion from ulcerative colitis to colorectal cancer.
    Gerçeker E; Boyacıoglu SO; Kasap E; Baykan A; Yuceyar H; Yıldırım H; Ayhan S; Ellidokuz E; Korkmaz M
    Oncol Rep; 2015 Oct; 34(4):1905-14. PubMed ID: 26259750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of FKBP51 in the prognosis of ulcerative colitis-associated colorectal cancer.
    Xia Z; Zhang G; Wang C; Feng Y
    Adv Med Sci; 2021 Mar; 66(1):89-97. PubMed ID: 33461100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.